Jason Drew Smith, General Counsel at UroGen Pharma Ltd. (URGN), sold 7,479 shares at $19.69 ($147K) on 2026-02-03, disclosed to the SEC on 2026-02-11.
Seasonal sale ($147k) by General Counsel — this insider has traded URGN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.69 | 1,608 | $32K | 21.5% |
| 2 | $19.69 | 2,654 | $52K | 35.5% |
| 3 | $19.69 | 3,217 | $63K | 43.0% |
| Total | $19.69 avg | 7,479 | $147K | 100% |
| Filing → |
| URGN | SELL | 2025-07-30 | $288K | — | Filing → |
| URGN | SELL | 2025-02-04 | $82K | — | Filing → |
| URGN | SELL | 2024-09-12 | $20K | — | Filing → |